DD267999A1 - PROCESS FOR THE PREPARATION OF 2-OXOGLUTARIC ACID BY YEAST - Google Patents
PROCESS FOR THE PREPARATION OF 2-OXOGLUTARIC ACID BY YEAST Download PDFInfo
- Publication number
- DD267999A1 DD267999A1 DD31206588A DD31206588A DD267999A1 DD 267999 A1 DD267999 A1 DD 267999A1 DD 31206588 A DD31206588 A DD 31206588A DD 31206588 A DD31206588 A DD 31206588A DD 267999 A1 DD267999 A1 DD 267999A1
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- oxoglutaric acid
- paraffins
- strain
- yeast
- preparation
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 11
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 9
- 238000000855 fermentation Methods 0.000 abstract description 9
- 230000004151 fermentation Effects 0.000 abstract description 9
- 239000008103 glucose Substances 0.000 abstract description 9
- 239000001963 growth medium Substances 0.000 abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052799 carbon Inorganic materials 0.000 abstract description 4
- 229960003495 thiamine Drugs 0.000 abstract description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract description 3
- 241000235013 Yarrowia Species 0.000 abstract description 3
- 235000019157 thiamine Nutrition 0.000 abstract description 3
- 239000011721 thiamine Substances 0.000 abstract description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 abstract description 3
- 239000011747 thiamine hydrochloride Substances 0.000 abstract description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000013586 microbial product Substances 0.000 abstract 1
- -1 n-paraffins Chemical compound 0.000 abstract 1
- 239000012188 paraffin wax Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000209202 Bromus secalinus Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000905012 Neonectria candida Species 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000187561 Rhodococcus erythropolis Species 0.000 description 1
- 208000005428 Thiamine Deficiency Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Die Erfindung bezieht sich auf ein Fermentationsverfahren zur Herstellung von 2-Oxoglutarsaeure mit einer stabilen, leistungsfaehigen Hefemutante des Stammes Yarrowia lipialytica H 222-27-11 ZIMET 43856 unter aeroben, submersen Bedingungen. Die Mutante ist in der Lage, unter Nutzung unterschiedlicher Kohlenstoffquellen, wie n-Paraffine, Glucose u. a., 2-Oxoglutersaeure in hoher Konzentration und mit hoher Geschwindigkeit im Kulturmedium zu akkumulieren. Unter den Bedingungen einer optimalen stammspezifischen Thiaminkonzentration von 0,05-0,15 mg/l Thiaminhydrochlorid werden bei einem p H-Wert von vorzugsweise 3,0-4,0 und einer Geloestsauerstoffkonzentration von 50-90%, besonders auf der Basis von n-Paraffinen, 125 g/l 2-Oxoglutarsaeure in 90 Stunden produziert. Die Anwendung der Erfindung liegt im Bereich der mikrobiellen Produktsynthese.The invention relates to a fermentation process for the preparation of 2-oxoglutaric acid with a stable, efficient yeast mutant of the strain Yarrowia lipialytica H 222-27-11 ZIMET 43856 under aerobic, submerged conditions. The mutant is capable of utilizing different sources of carbon, such as n-paraffins, glucose, and the like. a., 2-Oxoglutersaeure in high concentration and at high speed in the culture medium to accumulate. Under the conditions of an optimal strain-specific thiamine concentration of 0.05-0.15 mg / l of thiamine hydrochloride are at a p H value of preferably 3.0-4.0 and a Geloestsauerstoffkonzentration of 50-90%, especially based on n Paraffins, 125 g / l 2-oxoglutaric acid produced in 90 hours. The application of the invention is in the field of microbial product synthesis.
Description
Die Erfindung betrifft ein Verfahren zur Herstellung von 2-OxoglutarsSure durch Hefen mit geeigneten Kohlenstoffquellen untei aeroben, submorten Bedingungen und ist somit in das Gebiet der technischen Mikrobiologie einzuordnen.The invention relates to a process for the preparation of 2-OxoglutarsSure by yeasts with suitable carbon sources untei aerobic, submortional conditions and is thus classified in the field of technical microbiology.
2-Oxoflluiertäure findet zunehmend Interesse als Ausgangssubstanz für v/eiterführende chemische Synthesen. Sie kann chemisch nur in aufwendigen Mehrstufenverfahren hergestellt werden.2-oxofluoric acid is finding increasing interest as a starting material for advanced chemical syntheses. It can be prepared chemically only in complex multi-step process.
(GB 1.192905,1965, Prior. JP 38921,1964, Firma Kyowa Hakko Kogyo Co., Ltd.).(GB 1,192,905, 1965, Prior. JP 38921, 1964, Kyowa Hakko Kogyo Co., Ltd.).
der Basis von η-Paraffinen bevorzugt 2-Osoglutarsäure und auf der Basis von Glucose bevorzugt Brenztraubensäure ausscheiden (Ermakova, J.T. u.a. Frikladnaja Biochimija i Mikrobiologie 22 (1986| 3,341-347).Preferably, the base of η-paraffins precipitates 2-osoglutaric acid and, based on glucose, preferentially pyruvic acid (Ermakova, J. T., et al., Frikladnaja Biochimija i Mikrobiologie 22 (1986) 3,341-347).
2-Oxoglutarsiurekonzentration von 185g/l in 240h (Produktivität 0,9g/l · h) mit einer Ausbeute von 80%^ bezogen auf die eingesetzte Paratfinmenge, erzielt werden konnte.2-Oxoglutarsiurekonzentration of 185g / l in 240h (productivity 0.9g / l · h) with a yield of 80% ^ based on the Paratfinmenge used, could be achieved.
bekannt, daß eine Revertierung in haploide Formen mit geringerer Leistung auftreten kann.It is known that reversion can occur in lower power haploid forms.
Ziel der Erfindung ist es, mit einer Hefe aus unterschiedlichen Kohlenstoffquellen mittels eines Fermentationsverfahrens 2-Oxoglutarslure in hohen Endkonzentretionen und mit hoher Produktbildungsgeschwindigkeit herzustellen.The aim of the invention is to produce with a yeast from different carbon sources by means of a fermentation process 2-Oxoglutarslure in high final concentrations and with high product formation rate.
Aufgabe der Erfindung ist es, eine speziell hergestellte Hefemutante auszuwählen und unter spezifischen Verfahrensbedingungen zu kultivieren. Erfindungsgemfiß wird die Aufgabe dadurch gelöst, daß man den Hefestamm Yarrowia iipolytica H 222-27-11 (ZIMET 43856) in bekannten Nährmedien bei einem pH-Wo: i < 6,5, vorzugsweise von 3,0-4,0, einer optimalen, stammspezifischen Thiaminkonzentration von 0,05-0,1 5μg/l Thlamlrhydrochlorid, einer Temperatur von < 350C, bevorzugt 28-32'C und einer Gelöstsauerstoffkonzontration von 50-90% kultiviert.The object of the invention is to select a specially prepared yeast mutant and to cultivate it under specific process conditions. According to the invention, the object is achieved by optimally treating the yeast strain Yarrowia iipolytica H 222-27-11 (ZIMET 43856) in known nutrient media at a pH-Wo: i <6.5, preferably from 3.0-4.0 , strain-specific thiamine concentration of 0.05-0.1 5μg / l thlamol hydrochloride, a temperature of <35 0 C, preferably 28-32'C and a dissolved oxygen concentration of 50-90% cultured.
Der Stamm zeichnet sich dadurch aus, daß er auf den unterschiedlichsten assimilierbaren Kohlenstoffq'jellen, wie z. B. η-Paraffinen, Glucose, glucos>>naltigen Hydrolysaten, Invertzucker, Triglyceriden, Äthanol, Glycerin, Essigsäure bzw. Acetat in Gegenwart einer mineralischen Nihrsalzlösung sowie genau dosierten Wuchsstoffen und Vitamin B1 wichst und 2-Oxoglutartä. ·β akkumuliert. Besonders auf der Basis von η-Paraffinen werden große Mengen an 2-Oxoglutarsfiure mit hoher Produktionsbill lungsgeschwindigkeit und hoher Ausbeute, die die bisher bekannten übertreffen, produziert. So betragt die Produktionsbildungsgeschwindigkeit für 2-Oxoglutarsfiure aus n-Paraffinen durchschnittlich 1,4g/l h, d.h. dia Produktionsbildungsleistung ist um etwa 50% höher als die beschriebene Bestleistung mit einem diploiden Stamm, die erzielte die erzielte Ausbeute um etwa 10%.The strain is characterized by the fact that he on the most different assimilable Kohlenstoffq'jellen such. B. η-paraffins, glucose, glucos >> naltigen hydrolyzates, invert sugar, triglycerides, ethanol, glycerol, acetic acid or acetate in the presence of a mineral Nihrsalzlösung and precisely dosed growth factors and vitamin B1 wichst and 2-Oxoglutartä. · Β accumulates. Especially on the basis of η-paraffins are produced large amounts of 2-Oxoglutarsfiure high speed production and high yield, which exceed the previously known. Thus, the rate of production of 2-oxoglutaric acid from n-paraffins averages 1.4 g / l h, i. Production productivity is about 50% higher than the described best performance with a diploid strain, which achieved the yield achieved by about 10%.
Eine weitere wesentliche Eigenschaft des Stammes ist darin begründet, daß er unterschiedliche C-Quellen, wie z. B. nPa-affine und Glucose auch im Gemisch gleichzeitig verwerten kann oder aber, daß man unterschiedliche C-Quellen zu unterschiedlichen Zeiten verwendet, wie z. B. für die Wachstumsphase Paraffin und für die Produktbildungsphase Glucose oder umgekehrt. Der Stamm behält seine Eigenschaft, 2-O-oglutarsfiure in großen Mengen mit hoher Geschwindigkeit und hoher Ausbeute zu produzieren, unverändert über einen langen Test- Zeitraum von mehreren Jahren.Another essential feature of the strain is that it uses different C sources, such as. B. nPa affine and glucose in the mixture can recycle simultaneously or that you use different C sources at different times, such. For the growth phase paraffin and for the product formation phase glucose or vice versa. The strain retains its ability to produce 2-O-oglutarsfiure in high volumes at high speed and high yield, unchanged over a long test period of several years.
-2- 267-2- 267
zitronenslureproduzlereiiden Mutante H 222-27 dar.citric acid homologs mutant H 222-27 .
1. Morphologische Eigenschaften Kolonien nach *J8h auf YEP-G (1 % Hefeextrak), 2% Pepton, 2% Glucose, pH 5.5-6,0): etwa 2 mm groll, rund, weißgrau, glatt (spater faltig) mit glattem Rand. Zellen: deutlicher Dimorphismus, Hefezellen oval, von unterschiedlicher Größe Hyphen bilden Pseudomyzel1. Morphological characteristics Colonies after * J8h on YEP-G (1% yeast extract), 2% peptone, 2% glucose, pH 5.5-6.0): about 2 mm rum, round, white gray, smooth (later wrinkled) with smooth Edge. Cells: distinct dimorphism, yeast cells oval, of different size hyphae forming pseudomyzel
2. Physiologische Eigenschaften Subttratverwertung: Glucose +2. Physiological properties Subtrate utilization: glucose +
Fr uct ο te f Fructic f
Acetat +Acetate +
Äthanol +Ethanol +
n-Alkane +n-alkanes +
Zitronensäure + L-Sotbose -Citric Acid + L-Sotbose -
Glyzerin +Glycerine +
Galactosegalactose
Lactoselactose
MaltotaMaltota
SeccharoioSeccharoio --
Stärke KNOi Strength KNOi
Maximale Wachstumstemperatur: 25-32'C Vitaminbedarf: thiaminbedürftig 3. Genetische Eigenschaften Kernstalus: haploidMaximum growth temperature: 25-32'C Vitamin requirement: thiamin-needy 3. Genetic properties Kernstalus: haploid
Genotyp: A, melA, SUPA, SP01 In den nachfolgenden Beispielen wird die Erfindung nfiher erläutert;Genotype: A, melA, SUPA, SP01 In the following examples, the invention is explained in more detail;
werden 700mi η-Paraffine der Kettenlange C11-C1I zugesetzt.700mi η-paraffins of the chain C 11 -C 1 I are added.
lipolytica H 222-27-11, ZIMET 43856 als Inokulum zugesetzt.lipolytica H 222-27-11, ZIMET 43856 added as inoculum.
1 mg/1, MnSO4 · 4 H1015 my/I, ZnCI210mg/l, CoSo4 · 7H2O 4 mg/l, H]BOj 40mg/l, gelöst in destilliertem Wasser.1 mg / 1 MnSO4 · 4 H 1015 my / I, ZnCl 2 10mg / l, CoSO 4 · 7H 2 O 4 mg / l, H] BOJ 40mg / l, dissolved in distilled water.
3,5, pH-Regulation mit 40%iger NaOH.3.5, pH regulation with 40% NaOH.
mit einer hohen Produktbildungsgeschwindigkeit von durchschnittlich 1,4g/l · h.with a high product formation rate of on the average 1.4 g / l · h.
η-Paraffine in steriler Arbeitsweise zugegeben. Die Fermentation wird 100 Stunden fortgesetzt. Nach insgesamt 150 Produktionsstunden betragt die 2-OxoglutarsAurekonzentration 195g/l.η-paraffins added in a sterile procedure. The fermentation is continued for 100 hours. After a total of 150 hours of production, the 2-oxoglutaric acid concentration is 195 g / l.
BaIpIeI 3BaIpIeI 3
tu wird verfahren, wie im Beispiel 1 beschrieben worden ist, wob6i jedoch anstelle von Paraffin zur Produktbildung 450g/l Glucoto eingesetzt werden. Die Thiaminkonzentration wird auf 0,3 ug Thiaminhydrochlorid erhöht.The procedure is as described in Example 1, except that instead of paraffin for product formation 450 g / l Glucoto be used. The thiamine concentration is increased to 0.3 μg of thiamine hydrochloride.
16g/l Brenztraubensäure bestimmt.16g / l pyruvic acid determined.
Verfahren nach Beispiel 1, wobei anstelle von 700ml Paraffin zu Beginn der Fermentation ein Gemisch aus Paraffin (300ml) und Glucose (75g/l) als Kohlenstoffquellen vorgegeben werden. Nach 90 Stunden wird dia Fermentation abgebrochen. Die Konzentration der gebildeten 2-Oxoglutarsäure betragt 60g/l.Method according to Example 1, wherein instead of 700 ml paraffin at the beginning of the fermentation, a mixture of paraffin (300 ml) and glucose (75 g / l) are given as carbon sources. After 90 hours, the fermentation is stopped. The concentration of 2-oxoglutaric acid formed is 60 g / l.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD31206588A DD267999B5 (en) | 1988-01-06 | 1988-01-06 | PROCESS FOR THE PREPARATION OF 2-OXOGLUTARIC ACID BY YEAST |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD31206588A DD267999B5 (en) | 1988-01-06 | 1988-01-06 | PROCESS FOR THE PREPARATION OF 2-OXOGLUTARIC ACID BY YEAST |
Publications (2)
Publication Number | Publication Date |
---|---|
DD267999A1 true DD267999A1 (en) | 1989-05-17 |
DD267999B5 DD267999B5 (en) | 2000-08-10 |
Family
ID=5596428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD31206588A DD267999B5 (en) | 1988-01-06 | 1988-01-06 | PROCESS FOR THE PREPARATION OF 2-OXOGLUTARIC ACID BY YEAST |
Country Status (1)
Country | Link |
---|---|
DD (1) | DD267999B5 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055322A2 (en) | 2004-11-04 | 2006-05-26 | E.I. Dupont De Nemours And Company | High arachidonic acid producing strains of yarrowia lipolytica |
DE102007051452A1 (en) | 2007-10-27 | 2009-04-30 | Evonik Degussa Gmbh | Microbial reaction system, useful for the fermentative preparation of alpha-ketoglutaric acid, comprises recombinant microorganism and reaction medium, where an inactivation of the glutamate dehydrogenase is present in the microorganism |
DE102007051451A1 (en) | 2007-10-27 | 2009-04-30 | Evonik Degussa Gmbh | Microbial reaction system, useful for the fermentative preparation of alpha-ketoglutaric acid, comprises recombinant microorganism and reaction medium, where an inactivation of the glutamate dehydrogenase is present in the microorganism |
DE102009029651A1 (en) | 2009-09-22 | 2011-03-24 | Evonik Röhm Gmbh | Process for the preparation of free carboxylic acids |
EP2392664A2 (en) | 2003-05-07 | 2011-12-07 | E. I. du Pont de Nemours and Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
-
1988
- 1988-01-06 DD DD31206588A patent/DD267999B5/en active Search and Examination
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2392664A2 (en) | 2003-05-07 | 2011-12-07 | E. I. du Pont de Nemours and Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
EP2392665A2 (en) | 2003-05-07 | 2011-12-07 | E. I. du Pont de Nemours and Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
EP2402448A2 (en) | 2003-05-07 | 2012-01-04 | E. I. du Pont de Nemours and Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
WO2006055322A2 (en) | 2004-11-04 | 2006-05-26 | E.I. Dupont De Nemours And Company | High arachidonic acid producing strains of yarrowia lipolytica |
EP2458000A1 (en) | 2004-11-04 | 2012-05-30 | E. I. du Pont de Nemours and Company | High arachidonic acid producing strains of yarrowia lipolytica |
EP2649887A2 (en) | 2004-11-04 | 2013-10-16 | E. I. du Pont de Nemours and Company | High eicosapentaenoic acid producing strains of Yarrowia lipolytica |
DE102007051452A1 (en) | 2007-10-27 | 2009-04-30 | Evonik Degussa Gmbh | Microbial reaction system, useful for the fermentative preparation of alpha-ketoglutaric acid, comprises recombinant microorganism and reaction medium, where an inactivation of the glutamate dehydrogenase is present in the microorganism |
DE102007051451A1 (en) | 2007-10-27 | 2009-04-30 | Evonik Degussa Gmbh | Microbial reaction system, useful for the fermentative preparation of alpha-ketoglutaric acid, comprises recombinant microorganism and reaction medium, where an inactivation of the glutamate dehydrogenase is present in the microorganism |
DE102009029651A1 (en) | 2009-09-22 | 2011-03-24 | Evonik Röhm Gmbh | Process for the preparation of free carboxylic acids |
WO2011036000A1 (en) | 2009-09-22 | 2011-03-31 | Evonik Röhm Gmbh | Method for producing free carboxylic acids |
Also Published As
Publication number | Publication date |
---|---|
DD267999B5 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69720379T2 (en) | Process for the preparation of erythritol | |
DE69704900T2 (en) | Process for the preparation of aspartase and L-aspartic acid | |
EP2069515B1 (en) | Process for producing erythritol using moniliella tomentosa strains in the presence of inorganic nitrates as nitrogen source | |
DE3343576A1 (en) | METHOD FOR THE BIOTECHNOLOGICAL PRODUCTION OF POLY-D (-) - 3-HYDROXYBUTTERIC ACID | |
DE2417336A1 (en) | PROCESS FOR THE BIOTECHNICAL PRODUCTION OF L-LYSINE, L-ASPARAGIC ACID, L-ALANINE, L-VALIN, L-LEUCINE AND L-ARGININE AND MUTANTS FOR CARRYING OUT THE PROCESS | |
DE2301079C3 (en) | Process for the production of citric acid by microbiological means | |
DD267999A1 (en) | PROCESS FOR THE PREPARATION OF 2-OXOGLUTARIC ACID BY YEAST | |
DE3650395T2 (en) | Fermentation to obtain d-lactic acid. | |
DE2152039A1 (en) | Process for the production of bacterial cell mass | |
DE2358496C2 (en) | Production of L-Serine | |
DE69835903T2 (en) | Process for the preparation of [S, S] -ethylenediamine-N, N'-di-succinic acid | |
DE69737409T2 (en) | Process for the preparation of L-glutamic acid by continuous fermentation | |
DE2413961C2 (en) | Biotechnical production of citric acid | |
EP0997532A2 (en) | Process for the fermentative production of L-amino acids | |
DE2342912A1 (en) | PROCESS FOR PRODUCING L-HISTIDINE | |
DE2438206A1 (en) | PROCESS FOR THE BIOTECHNICAL PRODUCTION OF L-GLUTAMIC ACID AND MICROORGANISMS FOR CARRYING OUT THE PROCESS | |
DE69116198T2 (en) | Process for the preparation of D-isocitric acid by fermentation | |
DE3851108T2 (en) | METHOD FOR PRODUCING D-ALANINE. | |
EP0031553B1 (en) | Process for the production of glycerol dehydrogenase | |
DE2115514A1 (en) | Process for the production of citric acid | |
DE69930070T2 (en) | Fermentation process for the production of erythritol by means of new cells from Pichia | |
DE1792403C (en) | Process for the biotechnological production of L lysine | |
DE3320653A1 (en) | FERMENTATIVE METHOD FOR PRODUCING L-LEUCINE | |
DE3706724A1 (en) | Method for the cultivation of a microorganism of the genus Pseudomonas which produces amino-acid racemase | |
DE1792403B (en) | Process for the biotechnological production of L-lysine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RPI | Change in the person, name or address of the patentee (searches according to art. 11 and 12 extension act) | ||
RPV | Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act) | ||
EP | Request for examination under paragraph 12(1) filed | ||
RPI | Change in the person, name or address of the patentee (searches according to art. 11 and 12 extension act) | ||
ASS | Change of applicant or owner |
Owner name: UFZ - UMWELTFORSCHUNGSZENTRUM LEIPZIG-HALLE GMBH Effective date: 19970113 |
|
IF04 | In force in the year 2004 |
Expiry date: 20080107 |